Minerva Neurosciences, Inc. Long-Term Debt, Maturity, Year Two
Minerva Neurosciences, Inc. (NERV) had Long-Term Debt, Maturity, Year Two of $1.57 million as of 2015-09-30, per its 10-Q filed 2015-11-05.
Discontinued › Notes › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo · last filed 2015-11-05
- 2015-09-30: Long-Term Debt, Maturity, Year Two $1.57M.
- 2015-06-30: Long-Term Debt, Maturity, Year Two $3.14M.
- 2015-03-31: Long-Term Debt, Maturity, Year Two $3.14M.
| Period end | Long-Term Debt, Maturity, Year Two |
|---|---|
| 2015-09-30 | $1.57M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $3.14M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $3.14M 10-Q · filed 2015-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |